This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
post featured image

EU Pharma & Medical Device Regulation 2023
By Marco de Morpurgo Nicola Landolfi
Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
post featured image

European Commission proposes new rules on blood, tissues, and cells
By Marco de Morpurgo Nicola Landolfi
Today, the European Commission adopted a proposal for a new Regulation on standards of quality and safety for substances of human origin...
post featured image

Medicine promotion in Italy: Medicines Agency confirms increased 7% contribution due by 30 April 2022
By Nicola Landolfi
In a note published on 2 March 2022, the Italian Medicines Agency (AIFA) confirmed that all pharmaceutical companies must, by no later...
post featured image

European Commission proposes one-year postponement of MDR application date
By Mark Franklin Marco de Morpurgo Paula Gonzalez de Castejón Llano-Ponte +1 more...
Following an informal heads-up on 25 March 2020, today the European Commission adopted a proposed regulation to postpone by one year the...
post featured image

New transparency obligations for medical device companies in Italy
By Mark Franklin Nicola Landolfi
On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici (the Italian...